Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women

Gynecologic Oncology

Volumn 88, Issue 1, 2003, Pages 58-61

  Menczer, Joseph ^a   Chetrit, A ^b   Barda, G ^a   Lubin, F ^b   Fishler, Y ^b   Altaras, M ^c   Levavi, H ^d   Struewing, J P ^e   Sadetzki, S ^b   Modan, B ^f  

^a WOLFSON MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NONE

Author keywords

2,mutations; brca1; Ovarian carcinoma; Primary peritoneal carcinoma

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; DELETION MUTANT; DEMOGRAPHY; ETHNOLOGY; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; ISRAEL; MAJOR CLINICAL STUDY; MEDICAL RECORD; MUTATION RATE; ONCOGENE; OVARY CARCINOMA; PERITONEUM CANCER; PRIORITY JOURNAL;

EID: 0037227312     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6853     Document Type: Article

References (25)

1. White CD. Papillary intraperitoneal neoplasia resembling ovarian carcinoma after removal of benign ovaries. W V Med J 1993;89:282-3.
2. Kemp GM, Hsiu JG, Andrews MC. Papillary peritoneal carcinomatosis after prophilactic oophorectomy. Gynecol Oncol 1992;47:395-7.
3. Tobacman JK, Greene MH, Tucker MA, Costa J, Kase R, Fraumeni JF Jr. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian- cancer-prone families. Lancet 1982;2:795-7.
4. Piver MS, Jishi MF, Tsukada Y, and coauthors. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer: A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer 1993;71:2751-5.
5. Truong LD, Maccato ML, Awalt H, Cagle PT, Schwartz MR, Kaplan AL. Serous surface carcinoma of the peritoneum: A clonicopathologic study of 22 cases. Human Pathol 1990;21:99-110.
6. Eltabakh GH, Piver MS, Nataraian N, Metlin CJ. Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol 1998;1:254-9.
7. Chou CS, Menzin AW, Leonard DGB, Rubin SC, Wheeler E. Primary peritoneal carcinoma: A review of the literature. Obstet Gynecol Survey 1999;54:323-35.
8. Struewing JP, Conatty ZM, Ron E, and coauthors. Founder BRCA1/2 mutations among male patients with breast cancer in Israel Am J Human Genet 1999;65:1800-2.
9. Modan B, Hartge P, Hirsh-Yechezkel G, and coauthors. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and non carriers of a BRCA1 or BRCA2 mutation. N Engl J Med 2001;345:235-40.
10. Karlan BY, Baldwin RL, Lopez-Luevanos E, Raffel LJ, Barbuto D, Narod S, Platt LD. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: Implications for ovarian screening. AM J Obstet Gynecol 1999, 180:917-28.
11. Bandera CA, Schorge JO, Muto MG, Berkowitz RS, Rubin SC, Mok SC. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum. Obstet Gynecol 1998;92:596-600.
12. Halperin R, Zahavi S, Langer R, Hadas E, Bukovski I, Schneider D. Primary peritoneal papillary carcinoma: A new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int J Gynecol Cancer 2001, 11:403-8.
13. Modan B, Gac E, Bar Sade-Bruchim R, Hirsh-Yechezkel G, Theodor L, Lubin F, Ben-Baruch G, Beller U, Fishman A, Dgani R, Menczer J, Papa M, Friedman E. High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. JAMA 1996;276:1823-5.
14. Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. Gynecol Oncol 2000;78: 148-51.
15. Liede A, Karlan BY, Baldwin RL, Platt LD, Kuperstein G, Narod SA. Cancer incidence in a population of Jewish women at risk of ovarian cancer. J Clin Oncol 2002;20:1570-7.
16. Shiri-Swerdlof R, Oefner P, Green L, Gershoni-Baruch R, Wagner T, Kruglikova A, Haitchik S, Hofstra RMW, Papa M, Mulder I, Rizel S, Bruchim Bar-Sade R, Dagan E, Abdeen Z, Goldman B, Friedman E. Mutational analysis in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Human Mutat 2000;16:491-501.
17. Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, and coauthors. Clonal origin of epithelial ovarian carcinoma: Analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J Natl Cancer Inst 1992;84:1793-8.
18. Mok CH, Tsao SW, Knapp RC, Fishbaugh PM, Lau CC. Unifocal origin of advanced human epithelial ovarian cancers. Cancer Res 1992;52:5119-22.
19. Li S, Han H, Resnik E, Carcangiu ML, Schwartz PE, Yang-Feng TL. Advanced ovarian carcinoma: Molecular evidence of unifocal origin. Gynecol Oncol 1993;51:21-5.
20. Tsao SW, Mok CH, Knapp RC, Oike K, Muto MG, Welch WR, and coauthors. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol 1993;48:5-10.
21. Park TW, Felix JC, Wright TC Jr. X chromosome inactivation and macrosatellite instability in early and advanced bilateral ovarian carcinomas. Cancer Res 1995;55:4793-6.
22. Gallion HH, Guarino A, DePriest PD, van Nagel JR Jr, Vaccarello L, Berek JS, and coauthors. Evidence for a unifocal origin in familial ovarian cancer. Am J Obstet Gynecol 1996;174:1102-6.
23. Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, and coauthors. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res 1995;55:490-2.
24. Mol UM, Valea F, Chumas J. Role of p53 alteration in primary peritoneal carcinoma. Int J Gynecol Pathol 1997;16:156-2.
25. Schorge JO, Muto MG, Welch WR, and coauthors. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Nat Cancer Inst 1998;90:841-5.